Status:

TERMINATED

A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis

Lead Sponsor:

Sarepta Therapeutics, Inc.

Conditions:

Coronary Artery Disease

Coronary Stent Restenosis

Eligibility:

All Genders

19-80 years

Phase:

PHASE1

Brief Summary

The process of re-narrowing of a coronary artery following a revascularization procedure such as angioplasty, begins at the time of the procedure. Restenosis has long been considered a major problem f...

Detailed Description

The process of restenosis following a revascularization procedure, begins at the time of percutaneous coronary intervention (PCI). Restenosis has long been seen a major impediment of effective long-te...

Eligibility Criteria

Inclusion

  • ≥ 19 and ≤ 80 years of age.
  • The Subject must be properly consented following FDA regulations and guidelines.
  • Male and Female volunteers with reproductive or childbearing potential must agree to practice adequate birth control methods to protect themselves and partners from conception .
  • Subjects will be scheduled for percutaneous coronary intervention (PCI) due to first time implantation of a Taxus Express stent as a result of stenosis.
  • Subject is an acceptable candidate for coronary artery bypass surgery.
  • The Subject has no more than two lesions within the coronary arterial system requiring stent placement where the diameter of the affected artery or arteries is
  • ≥ 2.5 mm and ≤ 4.9 mm based on angiography.
  • The target lesion (and the secondary lesion, if applicable) is ≤ 20 mm in length via angiography.
  • The Subject has had successful placement of a Taxus Express intracoronary stent(s).
  • Subject agrees and is able to return for the scheduled study visits.

Exclusion

  • One or more treatable lesions within the coronary arterial system requiring planned or staged intervention prior to the Month One visit.
  • Multi-vessel coronary artery disease involving more than 2 vessels within the coronary arterial system requiring stent placement.
  • Clinically significant findings for any body system that the Principal Investigator determines will exclude a Subject from safely participating in the study.
  • A pregnant or nursing female.
  • Positive history for HIV, HBV or HCV.
  • In-stent restenosis in the target vessel.
  • A target lesion located in an unprotected left main coronary artery or aorto-ostial location or in a bypass graft.
  • Left ventricular ejection fraction \< 30%.
  • Angiographic evidence of the target vessel segment angulated ≥ 45º.
  • Angiographic evidence of thrombus or severe calcification in the target lesion.
  • History of bleeding disorders or coagulopathy.
  • NYHA Class III congestive heart failure (CHF).
  • Serum creatinine \> 1.5 mg/dL.
  • Clinically active cancer or any medical condition that may lead to study non-compliance or early study termination, confound the results, or is associated with limited life expectancy, i.e., less than 1 year.
  • History of a stroke or trans-ischemic attack (TIA) within 6 months of angioplasty.
  • Unstable ventricular arrhythmias.
  • Evidence of an acute myocardial infarction within 72 hours of the intended treatment (defined as: Q wave or non-Q wave infarction having CK enzymes ≥ 2X the upper laboratory normal with the presence of a CK-MB elevated above the upper limit of normal) or acute myocardial infarction in progress at time of treatment.
  • Known hypersensitivity to aspirin, clopidogrel, or heparin or a contraindication to receive the contrast agent administered during angiographic procedures.
  • Unwilling to accept blood transfusions.
  • Participant in an investigational device or drug study 30 days prior to randomization in this study.
  • A stent other than the Taxus Express is placed.
  • Unsuccessful intracoronary stent placement.

Key Trial Info

Start Date :

August 1 2003

Trial Type :

INTERVENTIONAL

End Date :

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT00244647

Start Date

August 1 2003

Last Update

April 10 2008

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.